Fiduciary Alliance’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.44M Buy
59,844
+5,153
+9% +$814K 0.71% 29
2026
Q2
$8.65M Buy
54,691
+19,481
+55% +$2.63M 0.59% 41
2026
Q1
$4.8M Buy
35,210
+32,017
+1,003% +$4M 0.29% 86
2025
Q4
$389K Sell
3,193
-440
-12% -$50.4K 0.03% 376
2025
Q3
$364K Sell
3,633
-727
-17% -$65.5K 0.02% 385
2025
Q2
$362K Buy
4,360
+323
+8% +$25.8K 0.03% 360
2025
Q1
$327K Sell
4,037
-483
-11% -$43.2K 0.03% 302
2024
Q4
$407K Sell
4,520
-19,446
-81% -$1.88M 0.04% 257
2024
Q3
$2.37M Buy
23,966
+648
+3% +$63.7K 0.31% 79
2024
Q2
$2.13M Buy
23,318
+285
+1% +$25.6K 0.35% 69
2024
Q1
$2.16M Buy
23,033
+1,789
+8% +$166K 0.38% 64
2023
Q4
$1.9M Sell
21,244
-237
-1% -$17.6K 0.37% 58
2023
Q3
$1.57M Buy
21,481
+593
+3% +$47.4K 0.36% 56
2023
Q2
$1.74M Buy
20,888
+1,768
+9% +$148K 0.37% 59
2023
Q1
$1.46M Sell
19,120
-348
-2% -$28.9K 0.37% 63
2022
Q4
$1.62M Buy
+19,468
New +$1.58M 0.42% 58

Other funds holding XBI

Fiduciary Alliance's XBI Position: Q3 2026 in Review

Fiduciary Alliance increased its State Street SPDR S&P Biotech ETF (XBI) stake by 9.4% in Q3 2026, buying an estimated $814K and bringing the position to 59,844 shares worth $9.44M. The position accounts for 0.71% of the portfolio, ranked #29.

Fiduciary Alliance first reported a position in XBI in Q4 2022 and has held it in 16 quarters since. 959 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Fiduciary Alliance held 59,844 shares of State Street SPDR S&P Biotech ETF worth $9.44M as of Q3 2026.
  • Fiduciary Alliance bought 5,153 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $814K.
  • State Street SPDR S&P Biotech ETF made up 0.71% of Fiduciary Alliance's portfolio in Q3 2026, its #29 holding.
  • Fiduciary Alliance first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 16 quarters since.
  • 959 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Fiduciary Alliance's 13F filing for Q3 2026, filed 13 Oct 2026.